Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
PDT response of H460 tumors after pretreatment with single- vs. triple-dose Erlotinib
| PDT | Erlotinib (single dose) + PDT | Erlotinib (triple dose) + PDT | |
|---|---|---|---|
| Median regrowth time in days (95% CI) | 11 (5,29) | 21 (10, undetermined)* | >90 (undetermined)** |
| 90-day complete response rate | 16% | 48% | 63% |
p=0.053 for comparison to PDT-alone and 0.042 for comparison to triple-dose regimen
p<0.001 for comparison to PDT-alone
